Items where Author is "Aleskandarany, MA"

Journal article

ELSHARAWY, K.A., TOSS, M.S., RAAFAT, S., BALL, G., GREEN, A.R., ALESKANDARANY, M.A., DALTON, L.W. and RAKHA, E.A., 2020. Prognostic significance of nucleolar assessment in invasive breast cancer. Histopathology, 76 (5), pp. 671-684. ISSN 0309-0167

ARORA, A., PARVATHANENI, S., ALESKANDARANY, M.A., AGARWAL, D., ALI, R., ABDEL-FATAH, T., GREEN, A.R., BALL, G.R., RAKHA, E.A., ELLIS, I.O., SHARMA, S. and MADHUSUDAN, S., 2017. Clinicopathological and functional significance of RECQL1 helicase in sporadic breast cancers. Molecular Cancer Therapeutics, 16 (1), pp. 239-250. ISSN 1535-7163

SHAMANNA, R.A., LU, H., CROTEAU, D.L., ARORA, A., AGARWAL, D., BALL, G., ALESKANDARANY, M.A., ELLIS, I.O., POMMIER, Y., MADHUSUDAN, S. and BOHR, V.A., 2016. Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer. Oncotarget, 7 (12). ISSN 1949-2553

ALESKANDARANY, M.A., AGARWAL, D., NEGM, O.H., BALL, G., ELMOUNA, A., ASHANKYTY, I., NUGLOZEH, E., FAZALUDEEN, M.F., DIEZ-RODRIGUEZ, M., NOLAN, C.C., TIGHE, P.J., GREEN, A.R., ELLIS, I.O. and RAKHA, E.A., 2016. The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts. Breast Cancer Research and Treatment, 156 (1), pp. 9-20. ISSN 0167-6806

ARORA, A., ABDEL-FATAH, T.M.A., AGARWAL, D., DOHERTY, R., CROTEAU, D.L., MOSELEY, P.M., HAMEED, K., GREEN, A., ALESKANDARANY, M.A., RAKHA, E.A., PATTERSON, K., BALL, G., CHAN, S.Y.T., ELLIS, I.O., BOHR, V.A., BRYANT, H.E. and MADHUSUDAN, S., 2016. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers. Carcinogenesis, 37 (1), pp. 63-71. ISSN 0143-3334

ARORA, A., ABDEL-FATAH, T.M.A., AGARWAL, D., DOHERTY, R., MOSELEY, P.M., ALESKANDARANY, M.A., GREEN, A.R., BALL, G., ALSHAREEDA, A.T., RAKHA, E.A., CHAN, S.Y.T., ELLIS, I.O. and MADHUSUDAN, S., 2015. Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer. Molecular Cancer Therapeutics, 14 (4), pp. 1057-1065. ISSN 1535-7163

ALESKANDARANY, M.A., NEGM, O.H., RAKHA, E.A., AHMED, M.A.H., NOLAN, C.C., BALL, G.R., CALDAS, C., GREEN, A.R., TIGHE, P.J. and ELLIS, I.O., 2012. TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome. Breast Cancer Research and Treatment, 136 (2), pp. 419-427. ISSN 0167-6806